|
1
|
Sunayama J, Sato A, Matsuda K, Tachibana
K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Sakurada K,
et al: FoxO3a functions as a key integrator of cellular signals
that control glioblastoma stem-like cell differentiation and
tumorigenicity. Stem Cells. 29:1327–1337. 2011.PubMed/NCBI
|
|
2
|
Jacobsen EA, Ananieva O, Brown Ml and
Chang Y: Growth, differentiation, and malignant transformation of
pre-B cells mediated by inducible activation of v-Abl oncogene. J
Immunol. 176:6831–6838. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ning Y, Luo C, Ren K, Quan M and Cao J:
FOXO3a-mediated suppression of the self-renewal capacity of
sphere-forming cells derived from the ovarian cancer SKOV3 cell
line by 7-difluoromethoxyl-5,4′-di-n-octyl genistein. Mol Med Rep.
9:1982–1988. 2014.PubMed/NCBI
|
|
4
|
Ning YX, Li QX, Ren KQ, Quan MF and Cao
JG: 7-difluoromethoxyl-5,4′-di-n-octyl genistein inhibits ovarian
cancer stem cell characteristics through the downregulation of
FOXM1. Oncol Lett. 8:295–300. 2014.PubMed/NCBI
|
|
5
|
Li Y, Wicha MS, Schwartz SJ and Sun D:
Implications of cancer stem cell theory for cancer chemoprevention
by natural dietary compounds. J Nutr Biochem. 22:799–806. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Oh J, Hlatky L, Jeong YS and Kim D:
Therapeutic effectiveness of anticancer phytochemicals on cancer
stem cells. Toxins. 8:pii: E199. 2016. View Article : Google Scholar :
|
|
7
|
Cunha-Rodrigues M, Portugal S, Prudêncio
M, Gonçalves LA, Casalou C, Buger D, Sauerwein R, Haas W and Mota
MM: Genistein-supplemented diet decreases malaria liver infection
in mice and constitutes a potential prophylactic strategy. PLoS
One. 3:e27322008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhou HB, Chen JM, Cai JT, Du Q and Wu CN:
Anticancer activity of genistein on implanted tumor of human SG7901
cells in nude mice. World J Gastroenterol. 14:627–631. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ning Y, Li Q, Xiang H, Liu F and Cao J:
Apoptosis induced by 7-difluoromethoxyl-5,4′-di-n-octyl genistein
via the inactivation of FoxM1 in ovarian cancer cells. Oncol Rep.
27:1857–1864. 2012.PubMed/NCBI
|
|
10
|
Montales MT, Rahal OM, Kang J, Rogers TJ,
Prior RL, Wu X and Simmen RC: Repression of mammosphere formation
of human breast cancer cells by soy isoflavone genistein and
blueberry polyphenolic acids suggests diet-mediated targeting of
cancer stem-like/progenitor cells. Carcinogenesis. 33:652–660.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chung H, Kim YH, Kwon M, Shin SJ, Kwon SH,
Cha SD and Cho CH: The effect of salinomycin on ovarian cancer
stem-like cells. Obstet Gynecol Sci. 59:261–268. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Latifi A, Luwor RB, Bilandzic M,
Nazaretian S, Stenvers K, Pyman J, Zhu H, Thompson EW, Quinn MA,
Findlay JK, et al: Isolation and characterization of tumor cells
from the ascites of ovarian cancer patients: Molecular phenotype of
chemoresistant ovarian tumors. PLoS One. 7:e468582012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vermeersch KA, Wang L, Mezencev R,
McDonald JF and Styczynski MP: OVCAR-3 spheroid-derived cells
display distinct metabolic profiles. PLoS One. 10:e01182622015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Condello S, Morgan CA, Nagdas S, Cao L,
Turek J, Hurley TD and Matei D: β-Catenin-regulated ALDH1A1 is a
target in ovarian cancer spheroids. Oncogene. 34:2297–2308. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xiang HL, Liu F, Quan MF, Cao JG and Lv Y:
7-difluoromethoxyl-5,4′-di-n-octylgenistein inhibits growth of
gastric cancer cells through downregulating forkhead box M1. World
J Gastroenterol. 18:4618–4626. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Zou T, Wang S, Chen H, Su D, Fu X,
Zhang Q and Kang X: Genistein-induced differentiation of breast
cancer stem/progenitor cells through a paracrine mechanism. Int J
Oncol. 48:1063–1072. 2016.PubMed/NCBI
|
|
17
|
Yao Y, Li W, Wu J, Germann UA, Su MS,
Kuida K and Boucher DM: Extracellular signal-regulated kinase 2 is
necessary for mesoderm differentiation. Proc Natl Acad Sci USA.
100:12759–12764. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang W, Wan C and Luo Q, Huang Z and Luo
Q: Genistein-inhibited cancer stem cell-like properties and reduced
chemoresistance of gastric cancer. Int J Mol Sci. 15:3432–3443.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang SD, Chen BC, Kao ST, Liu CJ and Yeh
CC: Genistein inhibits tumor invasion by suppressing multiple
signal transduction pathways in human hepatocellular carcinoma
cells. BMC Complement Altern Med. 14:262014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim SH, Kim SH, Kim YB, Jeon YT, Lee SC
and Song YS: Genistein inhibits cell growth by modulating various
mitogen-activated protein kinases and AKT in cervical cancer cells.
Ann NY Acad Sci. 1171:495–500. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
de Blas E, Estañ MC, de Del Carmen Gómez
Frutos M, Ramos J, Del Carmen Boyano-Adánez M and Aller P: Selected
polyphenols potentiate the apoptotic efficacy of glycolytic
inhibitors in human acute myeloid leukemia cell lines. Regulation
by protein kinase activities. Cancer Cell Int. 16:702016.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Y, Lu P, Zhang W, Du Q, Tang J, Wang
H, Lu J and Hu R: GEN-27, a newly synthetic isoflavonoid, inhibits
the proliferation of colon cancer cells in inflammation
microenvironment by suppressing NF-κB pathway. Mediators Inflamm.
2016:28530402016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vazquez-Santillan K, Melendez-Zajgla J,
Jimenez-Hernandez LE, Gaytan-Cervantes J, Muñoz-Galindo L,
Piña-Sanchez P, Martinez-Ruiz G, Torres J, Garcia-Lopez P,
Gonzalez-Torres C, et al: NF-kappaB-inducing kinase regulates stem
cell phenotype in breast cancer. Sci Rep. 6:373402016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jung Y, Park H, Zhao HY, Jeon R, Ryu JH
and Kim WY: Systemic approaches identify a garlic-derived chemical,
Z-ajoene, as a glioblastoma multiforme cancer stem cell-specific
targeting agent. Mol Cells. 37:547–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dubrovska A, Kim S, Salamone RJ, Walker
JR, Maira SM, García-Echeverría C, Schultz PG and Reddy VA: The
role of PTEN/Akt/PI3K signaling in the maintenance and viability of
prostate cancer stem-like cell populations. Proc Natl Acad Sci USA.
106:268–273. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
McGovern UB, Francis RE, Peck B, Guest SK,
Wang J, Myatt SS, Krol J, Kwok JM, Polychronis A, Coombes RC, et
al: Gefitinib (Iressa) represses FOXM1 expression via FOXO3a in
breast cancer. Mol Cancer Ther. 8:582–591. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jiang L, Cao XC, Cao JG, Liu F, Quan MF,
Sheng XF and Ren KQ: Casticin induces ovarian cancer cell apoptosis
by repressing FoxM1 through the activation of FOXO3a. Oncol Lett.
5:1605–1610. 2013.PubMed/NCBI
|
|
28
|
Steelman LS, Chappell WH, Abrams SL, Kempf
RC, Long J, Laidler P, Mijatovic S, Maksimovic-Ivanic D, Stivala F,
Mazzarino MC, et al: Roles of the Raf/MEK/ERK and
PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity
to therapy-implications for cancer and aging. Aging. 3:192–222.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Smalley KS, Haass NK, Brafford PA, Lioni
M, Flaherty KT and Herlyn M: Multiple signaling pathways must be
targeted to overcome drug resistance in cell lines derived from
melanoma metastases. Mol Cancer Ther. 5:1136–1144. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chahar MK, Sharma N, Dobhal MP and Joshi
YC: Flavonoids: A versatile source of anticancer drugs. Pharmacogn
Rev. 5:1–12. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sakariassen PO, Immervoll H and Chekenya
M: Cancer stem cells as mediators of treatment resistance in brain
tumors: Status and controversies. Neoplasia. 9:882–892. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang L, Li L, Jiao M, Wu D, Wu K, Li X,
Zhu G, Yang L, Wang X, Hsieh JT, et al: Genistein inhibits the
stemness properties of prostate cancer cells through targeting
Hedgehog-Gli1 pathway. Cancer Lett. 323:48–57. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roy SK, Srivastava RK and Shankar S:
Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of
FOXO transcription factor, leading to cell cycle arrest and
apoptosis in pancreatic cancer. J Mol Signal. 5:102010. View Article : Google Scholar : PubMed/NCBI
|
